D-0055-2018 Class II Terminated
FDA drug recall D-0055-2018 was initiated by AVKARE Inc. on Oct 6, 2017 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid. The recall status is terminated (terminated Mar 11, 2019). Affected quantity: 274 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 8, 2017
- Initiation Date
- Oct 6, 2017
- Termination Date
- Mar 11, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 274 cartons
Product description
Duloxetine Delayed-release Capsules USP, 20 mg, 50 Capsules (5 x 10) Unit Dose per carton, unit dose blister UPC 5026828311), Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-283-15.
Reason for recall
Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.
Distribution pattern
Nationwide in the USA
Code information
Lot: 18103 Exp. 11/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0055-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026